TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Conditions:   Tuberculosis;   Latent Tuberculosis Interventions:   Drug: Rifampin and Isoniazid;   Drug: isoniazid and rifapentine Sponsor:   Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Condition:   Tuberculosis Intervention:   Sponsor:   Tongji Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Conditions:   Tuberculosis;   Latent Tuberculosis Interventions:   Drug: Rifampin and Isoniazid;   Drug: isoniazid and rifapentine Sponsor:   Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Condition:   Tuberculosis Intervention:   Sponsor:   Tongji Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Conditions:   Tuberculosis;   Latent Tuberculosis Interventions:   Drug: Rifampin and Isoniazid;   Drug: isoniazid and rifapentine Sponsor:   Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Condition:   Tuberculosis Intervention:   Sponsor:   Tongji Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
Conditions:   Tuberculosis;   Latent Tuberculosis Interventions:   Drug: Rifampin and Isoniazid;   Drug: isoniazid and rifapentine Sponsor:   Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Condition:   Tuberculosis Intervention:   Sponsor:   Tongji Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
Condition:   Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials